1-2 of 2
Miguel Angel Piris, PhDMD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib: Preliminary Results from an Open-Label, Phase II Study in Relapsed or Refractory Peripheral T-Cell Lymphoma

Thomas E Witzig, MD, Lubomir Sokol, MD PhD, Eric Jacobsen, MD, Ranjana H. Advani, MD, Francine M Foss, MD, Rufino Mondejar, PhD, Miguel Angel Piris, PhDMD, James Bolognese, PhD, Francis Burrows, PhD, Linda Kessler, BA, Karen Bracken, MHS, Vishnu Mishra, PhD, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2788.
https://doi.org/10.1182/blood.V130.Suppl_1.2788.2788
Published: 2017
Journal Articles

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Zijun Yidan Xu-Monette, PhD, Li Yu, MD, Thai Tran, Lisa Adams, Nathan Roscoe, Ganiraju Manyam, Carlo Visco, Alexandar Tzankov, Karen Dybkær, PhD, Govind Bhagat, MD, April Chiu, MD, Wayne Tam, MD PhD, Youli Zu, MD PhD, Eric D. Hsi, MD, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, MD PhD, Maurilio Ponzoni, MD, Andres Ferreri, MD, Michael Boe Møller, Miguel Angel Piris, PhDMD, Jane N. Winter, MD, L. Jeffrey Medeiros, MD, George Rassidakis, MD PhD, Christine Angela Vaupel, PhD, Yong Li, PhD, Naveen Dakappagari, Ken H. Young, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 197.
https://doi.org/10.1182/blood.V130.Suppl_1.197.197
Published: 2017